Pharmaron Revenue and Competitors

Location

$907.8M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharmaron's estimated annual revenue is currently $208.6M per year.(i)
  • Pharmaron's estimated revenue per employee is $115,333
  • Pharmaron's total funding is $907.8M.

Employee Data

  • Pharmaron has 1809 Employees.(i)
  • Pharmaron grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M20%N/AN/A
#2
$32M1593%N/AN/A
#3
$35M1213%$62.5MN/A
#4
$30.2M15018%N/AN/A
#5
$135.3M6730%N/AN/A
#6
$14.9M11316%$173MN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

Pharmaron is a premier R&D service provider for the pharmaceutical industry. Founded in 2003, Pharmaron has invested in our people and our facilities enabling us to provide high quality R&D service across a number of disciplines including chemistry, biology, DMPK, pharmacology and chemical development. Pharmaron has grown steadily to meet the needs of our customers.

keywords:Biotechnology

$907.8M

Total Funding

1809

Number of Employees

$208.6M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharmaron's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVPReveal Email/Phone
3
CFOReveal Email/Phone
4
President/COOReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Chief Business OfficerReveal Email/Phone
7
SVP Medicinal ChemistryReveal Email/Phone
8
SVP, Business and Corporate DevelopmentReveal Email/Phone
9
VP, Cheminformatics and Comp. Chem.Reveal Email/Phone
10
SVP DMPKReveal Email/Phone

Pharmaron News

2022-04-20 - In Vitro ADME Testing Services Market Size And Forecast ...

Charles River Laboratories, Pharmaceutical Product Development (PPD), Pharmaron, Albany Molecular Research (AMRI), Galapagos, Tecan Group. The...

2022-03-22 - Pharmaron's cell and gene therapy webinar series ...

Pharmaron has taken their platform beyond small molecules and are pleased to now offer a full array of services for biologics and cell and...

2020-09-21 - PHARMARON BEIJING CO., LTD. Pharmaron Beijing : 2020 INTERIM REPORT

Pharmaron Beijing Co., Ltd.* (a joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 3759 2020 INTERIM REPORT For identification purposes only Premier R&D service provider for the life sciences industry About Pharmaron Pharmaron is a pre ...

2015-12-11 - Pharmaron Receives US$280M Investment

Pharmaron, a Beijing, China-based contract research organization (CRO), received an over US$280m investment. The consortium was led by CITIC M&A Fund and Legend Capital. The company intends to use the funds to further strengthen its core R&D service platforms to expand its existing R&D capabil ...

2011-03-03 - Pharmaron Finds $40M

Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. The firm said the new funding will go to expand its discovery ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$710.3M187941%N/A
#2
$681.6M1898N/AN/A
#3
$735.9M19062%$21.7M
#4
$478M195130%N/A
#5
$737.9M19524%N/A